𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Issues in antiemetic therapy

✍ Scribed by Barry R. Goldspiel; Gregory A. Curt

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
330 KB
Volume
77
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Granisetron as antiemetic therapy in chi
Granisetron as antiemetic therapy in children with cancer
✍ Craft, A. W. ;Price, L. ;Eden, O. B. ;Shaw, P. ;Campbell, R. ;Pierce, D. M. ;Mur πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 377 KB

## Abstract The safety and efficacy of the new 5HT‐3 antagonist granisetron as an antiemetic in children with cancer was evaluated in 40 children at a single dose of 40 ΞΌg/kg. No adverse affects attributable to the granisetron were noted. The overall major and complete response rate was 82.5% and t

Regulatory issues in cellular therapies
Regulatory issues in cellular therapies
✍ Adrian P. Gee πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

Cellular and gene therapies offer considerable promise as new treatment modalities. The Food and Drug Administration has been developing strategies to regulate these rapidly evolving fields in a manner that sustains progress and also ensures minimization of potential risks. The death of a patient on